Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
about
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary glandPotential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancerDiscovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/DoxHypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatmentLymphoma and myeloma cell resistance to cytotoxic agents and ionizing radiations is not affected by exposure to anti-IL-6 antibodySTAT3 can be activated through paracrine signaling in breast epithelial cells.Postoperative fever: the potential relationship with prognosis in node negative breast cancer patientsSystematic analysis of secreted proteins reveals synergism between IL6 and other proteins in soft agar growth of MCF10A cellsCytokine plasma levels: reliable predictors for radiation pneumonitis?A quantitative high-throughput screen for modulators of IL-6 signaling: a model for interrogating biological networks using chemical librariesSpatiotemporal Changes in P-glycoprotein Levels in Brain and Peripheral Tissues Following Ischemic Stroke in RatsTargeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growthChanges in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancerChallenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast CancerMolecular pathways: regulation and therapeutic implications of multidrug resistanceProfiling human protein degradome delineates cellular responses to proteasomal inhibition and reveals a feedback mechanism in regulating proteasome homeostasis.Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells.Ah receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines.Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model.IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway.CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases.Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer.Celastrol blocks interleukin-6 gene expression via downregulation of NF-κB in prostate carcinoma cellsInterleukin-6 and pro inflammatory status in the breast tumor microenvironmentBreast cancer stem cells, cytokine networks, and the tumor microenvironment.The two faces of Janus kinases and their respective STATs in mammary gland development and cancerInterleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activationGonadotropin-mediated chemoresistance: Delineation of molecular pathways and targetsMethylation-controlled J protein promotes c-Jun degradation to prevent ABCB1 transporter expression.Overexpression of IL-7 enhances cisplatin resistance in gliomaInterleukin-6 and its receptor, key players in hepatobiliary inflammation and cancerIL-6 involvement in epithelial cancers.Hyperthermia increases interleukin-6 in mouse skeletal muscle.Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiationDownregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies.Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression functionMage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases.Synergistic effect of the γ-secretase inhibitor PF-03084014 and docetaxel in breast cancer models.Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells.
P2860
Q24669531-88DD032F-1A3D-44C0-A15F-BC79A645C429Q26769917-FE523667-94B2-4BBF-8C18-1BE60F8DADB5Q28477021-F1665A58-F965-432F-B752-0D5610D1E545Q28484357-BE02D7B3-ECCB-477B-8E7B-7ED0ED25C194Q28750048-371612B3-D8F5-4B77-859A-E1658B1CAF46Q30849602-BB6C3F21-07FF-4F1F-BD34-ECE0DC0197C5Q30994909-39BB2D30-B494-4C96-833F-EE0220897ADFQ31021549-E747E453-2568-4C9C-9A8E-DAC1BA81D6AFQ33358117-84647E84-F3B0-49C1-8CED-211DDF2FA99CQ33492390-9C7EF840-A157-454B-B722-B743F4B6B03AQ33583533-3B228024-7A74-4E91-AD72-5B3A0310675FQ33674790-61EA788A-0FF7-4C4B-B4BD-62EE483BDEE3Q33739585-BEFD3F85-271E-4336-AD46-A2166EA278C0Q33760216-52B3388D-6B69-444B-8B95-D325EEEBA7A1Q34255292-2ECE942D-00F4-4F03-AE05-441C3672D85DQ34289909-BAC80BB9-2A50-437F-BA32-503535BC9210Q34405506-D917167A-F346-4243-A166-23407F97822AQ34523687-3CA6A848-A16A-47AD-87CA-4C4309DC0596Q34605176-C3DB36EB-0DEA-4DE3-B7A4-5DF8486C0F4CQ34646864-8236968F-0FD7-44FD-AFA4-1BAAE5ED80B1Q34804514-D36FD569-2F69-4D87-B773-937C6044552DQ34983912-1E293E07-D267-4250-BFB1-58B34CCBFFA5Q35007044-36E1FFA6-D7BF-4357-872C-FBD6F4503F05Q35130330-99BC933F-0A5D-4DBC-A939-E8125F4EE8D2Q35427020-368FB8F3-6374-4CCF-B5BC-C1ED989CB4EFQ35571904-5FE91146-51D5-45DC-B7BF-7DA85958FA9CQ35685851-A48BF963-C11E-4C94-A08E-EC16BCB282AFQ35713579-C45F6E48-AAB5-4A3E-B039-00D822CBFF44Q35853333-72D4B918-9B2F-4B5E-BB82-18573BE2849EQ35856811-B99A6830-B68B-4111-A514-D97D8AC292B4Q36000273-2F1C292F-4038-41B8-A2B4-09026BFFDD14Q36042724-AB13F6C0-5B82-4228-B906-393C8660ECE4Q36173590-D8967472-3DAC-4192-92E8-F896A1D37839Q36175606-9035777D-1783-4890-B937-C92AD33FB3A9Q36371096-044039D5-025D-46B6-9F58-07330D6CA8ADQ36608759-62A5887D-0C8E-42BC-B02C-40ACC35905E7Q36696643-3BF62FBE-7801-4455-A3E9-79269ABBDD96Q36859171-EFD9EA37-0986-470D-AAE2-5BD042D2520EQ36861775-B5430D42-933B-437D-AC39-B5A6BA05EAC0Q36940631-39E89EA5-F70B-4221-AB27-2D92FEE308C2
P2860
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
@ast
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
@en
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
@nl
type
label
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
@ast
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
@en
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
@nl
prefLabel
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
@ast
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
@en
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
@nl
P2093
P1433
P1476
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells
@en
P2093
P304
P407
P577
2001-12-01T00:00:00Z